Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease

FASEB Journal

Volumn 31, Issue 9, 2017, Pages 4168-4178

  Royce, Simon G ^a   Rele, Siddharth ^a   Broughton, Brad R S ^a   Kelly, Kilian ^b   Samuel, Chrishan S ^a  

^a MONASH UNIVERSITY   (Australia)

^b Cynata Therapeutics Limited   (Australia)

Author keywords

Airway remodeling; Asthma; Pulmonary delivery; Therapies

Indexed keywords

COLLAGEN; GELATINASE; HYDROXYPROLINE; OVALBUMIN; TRANSFORMING GROWTH FACTOR BETA1;

AIRWAY REMODELING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CHRONIC DISEASE; CONTROLLED STUDY; DRY WEIGHT; FEMALE; GOBLET CELL; HEMANGIOBLAST; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INDUCED PLURIPOTENT STEM CELL; INTERMETHOD COMPARISON; INTRANASAL MESENCHYMAL STEM CELL TRANSPLANTATION; INTRAVENOUS MESENCHYMAL STEM CELL TRANSPLANTATION; LUNG FIBROSIS; LUNG LOBE; LUNG PARENCHYMA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMOANGIOBLAST DERIVED MESENCHYMAL STEM CELL; METAPLASIA; MOUSE; MYOFIBROBLAST; NONHUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT ALLERGY; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; HYPERSENSITIVITY; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; MESENCHYMAL STROMA CELL; PROCEDURES; PULMONARY FIBROSIS; RESPIRATORY HYPERSENSITIVITY; STEM CELL TRANSPLANTATION;

ADMINISTRATION, INTRANASAL; AIRWAY REMODELING; ANIMALS; FEMALE; GOBLET CELLS; HYPERSENSITIVITY; MESENCHYMAL STROMAL CELLS; METAPLASIA; MICE; MICE, INBRED BALB C; OVALBUMIN; PULMONARY FIBROSIS; RESPIRATORY HYPERSENSITIVITY; STEM CELL TRANSPLANTATION;

EID: 85028806877     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201700178R     Document Type: Article

References (52)

1. Braman, S. S. (2006) The global burden of asthma. Chest 130 (1 Suppl), 4S–12S
2. Holgate, S. T., Arshad, H. S., Roberts, G. C., Howarth, P. H., Thurner, P., and Davies, D. E. (2009) A new look at the pathogenesis of asthma. Clin. Sci. (Lond) 118, 439–450
3. Royce, S. G., Moodley, Y., and Samuel, C. S. (2014) Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis. Pharmacol. Ther. 141, 250–260
4. Nelson, H. S., Weiss, S. T., Bleecker, E. R., Yancey, S. W., and Dorinsky, P. M.; SMART Study Group. (2006) The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129, 15–26
5. Cates, C. J., Jaeschke, R., Schmidt, S., and Ferrer, M. (2013) Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst. Rev. 3, CD006922
6. Cates, C. J., Jaeschke, R., Schmidt, S., and Ferrer, M. (2013) Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst. Rev. 6, CD006924
7. Wener, R. R., and Bel, E. H. (2013) Severe refractory asthma: an update. Eur. Respir. Rev. 22, 227–235
8. Reddel, H. K., Jenkins, C. R., Marks, G. B., Ware, S. I., Xuan, W., Salome, C. M., Badcock, C. A., and Woolcock, A. J. (2000) Optimal asthma control, starting with high doses of inhaled budesonide. Eur. Respir. J. 16, 226–235
9. Adams, N. P., Bestall, J. C., Jones, P., Lasserson, T. J., Griffiths, B., and Cates, C. J. (2008) Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst. Rev. 4, CD003534
10. Knight, D. A., Rossi, F. M., and Hackett, T. L. (2010) Mesenchymal stem cells for repair of the airway epithelium in asthma. Expert Rev. Respir. Med. 4, 747–758
11. Sueblinvong, V., and Weiss, D. J. (2010) Stem cells and cell therapy approaches in lung biology and diseases. Transl. Res. 156, 188–205
12. Abreu, S. C., Antunes, M. A., Maron-Gutierrez, T., Cruz, F. F., Ornellas, D. S., Silva, A. L., Diaz, B. L., Ab’Saber, A. M., Capelozzi, V. L., Xisto, D. G., Morales, M. M., and Rocco, P. R. (2013) Bone marrow mononuclear cell therapy in experimental allergic asthma: intratracheal versus intravenous administration. Respir. Physiol. Neurobiol. 185, 615–624
13. Martínez-González, I., Cruz, M. J., Moreno, R., Morell, F., Muñoz, X., and Aran, J. M. (2014) Human mesenchymal stem cells resolve airway inflammation, hyperreactivity, and histopathology in a mouse model of occupational asthma. Stem Cells Dev. 23, 2352–2363
14. Inamdar, A. C., and Inamdar, A. A. (2013) Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell. Exp. Lung Res. 39, 315–327
15. Royce, S. G., Shen, M., Patel, K. P., Huuskes, B. M., Ricardo, S. D., and Samuel, C. S. (2015) Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease. Stem Cell Res. (Amst.) 15, 495–505
16. Urbanek, K., De Angelis, A., Spaziano, G., Piegari, E., Matteis, M., Cappetta, D., Esposito, G., Russo, R., Tartaglione, G., De Palma, R., Rossi, F., and D’Agostino, B. (2016) Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model. PLoS One 11, e0158746
17. Gao, F., Chiu, S. M., Motan, D. A., Zhang, Z., Chen, L., Ji, H. L., Tse, H. F., Fu, Q. L., and Lian, Q. (2016) Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 7, e2062
18. Goodwin, M., Sueblinvong, V., Eisenhauer, P., Ziats, N. P., LeClair, L., Poynter, M. E., Steele, C., Rincon, M., and Weiss, D. J. (2011) Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells 29, 1137–1148
19. Ou-Yang, H. F., Huang, Y., Hu, X. B., and Wu, C. G. (2011) Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells. Exp. Biol. Med. (Maywood) 236, 1461–1467
20. Zeng, S. L., Wang, L. H., Li, P., Wang, W., and Yang, J. (2015) Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function. Mol. Med. Rep. 12, 2511–2520
21. Ogulur, I., Gurhan, G., Aksoy, A., Duruksu, G., Inci, C., Filinte, D., Kombak, F. E., Karaoz, E., and Akkoc, T. (2014) Suppressive effect of compact bone-derived mesenchymal stem cells on chronic airway remodeling in murine model of asthma. Int. Immunopharmacol. 20, 101–109
22. Lim, R., Milton, P., Murphy, S. V., Dickinson, H., Chan, S. T., and Jenkin, G. (2013) Human mesenchymal stem cells reduce lung injury in immunocompromised mice but not in immunocompetent mice. Respiration 85, 332–341
23. Kapoor, S., Patel, S. A., Kartan, S., Axelrod, D., Capitle, E., and Rameshwar, P. (2012) Tolerance-like mediated suppression by mesenchymal stem cells in patients with dust mite allergy-induced asthma. J. Allergy Clin. Immunol. 129, 1094–1101
24. Mancheño-Corvo, P., Menta, R., del Río, B., Franquesa, M., Ramírez, C., Hoogduijn, M. J., DelaRosa, O., Dalemans, W., and Lombardo, E. (2015) T lymphocyte prestimulation impairs in a time-dependent manner the capacity of adipose mesenchymal stem cells to inhibit proliferation: role of interferon g, poly I:C, and tryptophan metabolism in restoring adipose mesenchymal stem cell inhibitory effect. Stem Cells Dev. 24, 2158–2170
25. Weiss, D. J. (2014) Concise review: current status of stem cells and regenerative medicine in lung biology and diseases. Stem Cells 32, 16–25
26. Vodyanik, M. A., Yu, J., Zhang, X., Tian, S., Stewart, R., Thomson, J. A., and Slukvin, I. I. (2010) A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell 7, 718–729
27. Royce, S. G., Sedjahtera, A., Samuel, C. S., and Tang, M. L. (2013) Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease. Clin. Sci. 124, 41–51
28. Royce, S. G., Tominaga, A. M., Shen, M., Patel, K. P., Huuskes, B. M., Lim, R., Ricardo, S. D., and Samuel, C. S. (2016) Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease. Clin. Sci. 130, 2151–2165
29. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, Dj., and Horwitz, E. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317
30. Gallop, P. M., and Paz, M. A. (1975) Posttranslational protein modifications, with special attention to collagen and elastin. Physiol. Rev. 55, 418–487
31. Woessner, J. F., Jr. (1995) Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol. 248, 510–528
32. Royce, S. G., Lim, C., Muljadi, R. C., Samuel, C. S., Ververis, K., Karagiannis, T. C., Giraud, A. S., and Tang, M. L. (2013) Trefoil factor-2 reverses airway remodeling changes in allergic airways disease. Am. J. Respir. Cell Mol. Biol. 48, 135–144
33. Koch, J. M., D’Souza, S. S., Schwahn, D. J., Dixon, I., and Hacker, T. A. (2016) Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice. Cytotherapy 18, 219–228
34. Cohn, L., Elias, J. A., and Chupp, G. L. (2004) Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22, 789–815
35. Sun, Y. Q., Deng, M. X., He, J., Zeng, Q. X., Wen, W., Wong, D. S., Tse, H. F., Xu, G., Lian, Q., Shi, J., and Fu, Q. L. (2012) Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice. Stem Cells 30, 2692–2699
36. Cho, K. S., Park, M. K., Mun, S. J., Park, H. Y., Yu, H. S., and Roh, H. J. (2016) Indoleamine 2,3-Dioxygenase is not a pivotal regulator responsible for suppressing allergic airway inflammation through adipose-derived stem cells. PLoS One 11, e0165661
37. Mathias, L. J., Khong, S. M., Spyroglou, L., Payne, N. L., Siatskas, C., Thorburn, A. N., Boyd, R. L., and Heng, T. S. (2013) Alveolar macrophages are critical for the inhibition of allergic asthma by mesenchymal stromal cells. J. Immunol. 191, 5914–5924
38. Shifren, A., Witt, C., Christie, C., and Castro, M. (2012) Mechanisms of remodeling in asthmatic airways. J. Allergy (Cairo) 2012, 316049
39. Cohen, L., E, X., Tarsi, J., Ramkumar, T., Horiuchi, T. K., Cochran, R., DeMartino, S., Schechtman, K. B., Hussain, I., Holtzman, M. J., and Castro, M.; NHLBI Severe Asthma Research Program (SARP). (2007) Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am. J. Respir. Crit. Care Med. 176, 138–145
40. Carsin, A., Mazenq, J., Ilstad, A., Dubus, J. C., Chanez, P., and Gras, D. (2016) Bronchial epithelium in children: a key player in asthma. Eur. Respir. Rev. 25, 158–169
41. Patel, K. P., Giraud, A. S., Samuel, C. S., and Royce, S. G. (2016) Combining an epithelial repair factor and anti-fibrotic with a corticosteroid offers optimal treatment for allergic airways disease. Br. J. Pharmacol. 173, 2016–2029
42. Holgate, S. T. (2008) Pathogenesis of asthma. Clin. Exp. Allergy 38, 872–897
43. Holgate, S. T., and Davies, D. E. (2009) Rethinking the pathogenesis of asthma. Immunity 31, 362–367
44. Formigli, L., Perna, A. M., Meacci, E., Cinci, L., Margheri, M., Nistri, S., Tani, A., Silvertown, J., Orlandini, G., Porciani, C., Zecchi-Orlandini, S., Medin, J., and Bani, D. (2007) Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling. J. Cell. Mol. Med. 11, 1087–1100
45. Huuskes, B. M., Wise, A. F., Cox, A. J., Lim, E. X., Payne, N. L., Kelly, D. J., Samuel, C. S., and Ricardo, S. D. (2015) Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy. FASEB J. 29, 540–553
46. Samuel, C. S., Summers, R. J., and Hewitson, T. D. (2016) Antifibrotic actions of serelaxin - new roles for an old player. Trends Pharmacol. Sci. 37, 485–497
47. Rolfe, K. J., and Grobbelaar, A. O. (2012) A review of fetal scarless healing. ISRN Dermatol. 2012, 698034
48. Holgate, S. T. (2000) Epithelial damage and response. Clin. Exp. Allergy 30 (Suppl 1), 37–41
49. Hastie, A. T., Kraft, W. K., Nyce, K. B., Zangrilli, J. G., Musani, A. I., Fish, J. E., and Peters, S. P. (2002) Asthmatic epithelial cell proliferation and stimulation of collagen production: human asthmatic epithelial cells stimulate collagen type III production by human lung myofibroblasts after segmental allergen challenge. Am. J. Respir. Crit. Care Med. 165, 266–272
50. Curran, D. R., and Cohn, L. (2010) Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease. Am. J. Respir. Cell Mol. Biol. 42, 268–275
51. Broide, D. H. (2008) Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J. Allergy Clin. Immunol. 121, 560–570; quiz 571–562
52. Pitchford, S., and Page, C. (2003) Extracellular matrix composition influences the resistance of airway remodelling events towards glucocorticoid treatment. Br. J. Pharmacol. 138, 1181–1182